about
Diagnostic utility of data from adrenal venous sampling for primary aldosteronism despite failed cannulation of the right adrenal vein.Population-Level Incidence and Predictors of Surgically Induced Diabetes and Exocrine Insufficiency after Partial Pancreatic Resection.Zollinger-Ellison syndrome: classical considerations and current controversies.Quality of life in patients after total pancreatectomy is comparable with quality of life in patients who undergo a partial pancreatic resection.Defining the post-operative morbidity index for distal pancreatectomy.External carotid artery stenosis after internal and common carotid stenting.Limitations of ACS-NSQIP in reporting complications for patients undergoing pancreatectomy: underscoring the need for a pancreas-specific module.Demographic features and natural history of intermediate-risk multifocal versus unifocal intraductal papillary mucinous neoplasms.Differences in single gland and multigland disease are seen in low biochemical profile primary hyperparathyroidism.Neoadjuvant therapy and vascular resection during pancreaticoduodenectomy: shifting the survival curve for patients with locally advanced pancreatic cancer.Analysis of Perioperative Chemotherapy in Resected Pancreatic Cancer: Identifying the Number and Sequence of Chemotherapy Cycles Needed to Optimize Survival.Effect of race and insurance status on outcomes after vascular access placement for hemodialysis.Single-Institution Experience with Irreversible Electroporation for T4 Pancreatic Cancer: First 50 Patients.Establishing a quantitative benchmark for morbidity in pancreatoduodenectomy using ACS-NSQIP, the Accordion Severity Grading System, and the Postoperative Morbidity Index.Readmission after pancreatic resection is not an appropriate measure of quality.Predictors of recurrence in intraductal papillary mucinous neoplasm: experience with 183 pancreatic resections.Short-term but not long-term loss of patency of venous reconstruction during pancreatic resection is associated with decreased survival.The vascular surgeon's experience with adrenal venous sampling for the diagnosis of primary hyperaldosteronism.Expanding the indications for laparoscopic retroperitoneal adrenalectomy: experience with 81 resections.Suppression of calbindin D28K in estrogen-induced hamster renal tumors.Positron emission tomography (PET) has limited utility in the staging of pancreatic adenocarcinoma.Tip appendicitis: clinical implications and management.Charge Variability for Acute Appendicitis: Is the Problem Overstated?Quantitative analysis of total mitochondrial DNA: Competitive polymerase chain reaction versus real-time polymerase chain reaction
P50
Q31001372-CBF8E46C-090F-4B7B-9243-7668D4CD936EQ33564979-1ED18620-B4EC-49B6-A227-7F0E06E9A3A7Q34390574-AF571025-4D4D-421C-8B0D-FD51C3BE4F9DQ34397045-6F283D76-74F0-44B2-850C-82094C5F021AQ34548917-0A5DEEF1-95BB-4005-B4E7-C9A4A0230F01Q35478136-110A989D-4348-4E29-92E5-4E113C1DB2D6Q38177191-23EB9213-95A0-4F92-B4B8-3C6FF2A416EEQ38269881-BA7BB442-65E6-43D0-BBC4-6DB79248A71AQ39009523-7EE088A7-ADE0-465E-9F0B-F6ADC2D5CC55Q39199977-4B12B63F-88EC-4060-AA24-D0FAA2C3AAE7Q39417171-749114E5-BBFF-41DE-8102-D8CFCFA58461Q40160266-A3B562F1-8E98-4565-B871-5F836F2C2264Q40160978-9990F3F4-AE99-420C-AAC4-BCB146D52723Q41721820-80165F50-9378-4769-B8A3-6A2A1FC018A8Q42680163-AABE7ADE-2AE7-4B7B-BC34-6146855D2ACDQ43494998-39653B87-09EA-47FB-85FD-EC75063E6C7AQ44034232-9AC1A357-AE36-4BDE-A650-12FA3B42A4F3Q44568500-CAB86D18-CA73-4170-80BF-592104CB769DQ44645136-9379B853-5B7B-47B0-B88F-55B3ECEACAF4Q45255542-F30BF528-CC85-4376-92D4-0E37168B4617Q45906386-0DFB02C8-0778-47F2-8BD6-C5D00D698000Q53394732-45D7F318-0227-46C4-8BC5-0429CECC6B6EQ61794046-4430DEB3-8EFF-4C25-BB4E-0B7F7FBD9AE5Q61794052-A4D189F9-2823-4849-8283-27857CE870A3
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Irene Epelboym
@ast
Irene Epelboym
@en
Irene Epelboym
@es
Irene Epelboym
@sl
type
label
Irene Epelboym
@ast
Irene Epelboym
@en
Irene Epelboym
@es
Irene Epelboym
@sl
prefLabel
Irene Epelboym
@ast
Irene Epelboym
@en
Irene Epelboym
@es
Irene Epelboym
@sl
P106
P21
P31
P496
0000-0002-5571-4612